Measurement and Sigma Metrics

Size: px
Start display at page:

Download "Measurement and Sigma Metrics"

Transcription

1 Measurement and Sigma Metrics Tony Badrick 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

2 Measurement is the first step that leads to control and eventually to improvement. If you can t measure something, you can t understand it. If you can t understand it, you can t control it. If you can t control it, you can t improve it RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

3 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

4 EQA driving Improvement 90% of the EQA problems were resolved after the first round of EQA and 99% were resolved by the third round, suggesting that the laboratories had successfully corrected mistakes identified by EQA performance. Hoeltge FA, Phillips MG, Styer PE, Mockridge P (2005) Detection and correction of systematic laboratory problems by analysis of clustered proficiency testing failures. Arch Pathol Lab Med.129(2): Poor PT/EQA performance because of interpretation errors has decreased between 1997 and This may be derived from continued participation in PT/EQA. Ramsden SC, Deans Z, Robinson DO, et al (2006) Monitoring standards for molecular genetic testing in the United Kingdom, The Netherlands and Ireland. Genetic Test 10(3):

5

6 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

7 Roadmap to selecting the optimal Westgard QC rule for a test Collect the general test characteristics CVa, bias and TEa CVa (%): calculate the total analytical variation coefficient (intra and inter analytical) from a period long enough to yield a representative impression of the performance of the test (it is recommended to discard outliers). This information can be derived from results of your internal QC program. Bias (%): calculate the systematic difference between the mean of your test results compared to the mean of the results acquired with a reference method or of a group mean. This information can be collected from results of an external QC program and should also cover a representative period. In fact, if comparison with a reference method is not possible, consider using state-of-art or consensus values.

8 Roadmap to selecting the optimal Westgard QC rule for a test 1. TEa (%): read the value of TEa is defined as desirable specification for allowable error and referred to as desirable TE or TEd by Ricos et al.). 2. Calculate the Sigma value of the test using the formula: Sigma as (TEa bias)/cva. 3. Select the optimal Westgard QC (multi)rule. As the Sigma value of the Westgard rules decreases, stringency increases as does the chance of missing an error (p error detection decreases). Therefore, the best Westgard rule is the one with a Sigma value closest to, but smaller than, the Sigma value of the test.

9 Capability Classes Cps less than 3 : Incapable Cps between 3 and 4: Barely capable Cps between 4 and 6: Capable Cps greater than 6: Highly capable (World class) Defects per million 3 sigma 2700/ sigma 63/ sigma.57/ sigma.002/ RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

10

11

12

13 Allowable Limits of Performance based on Biological Variability Monitoring Diagnostic

14

15 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

16

17 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

18

19 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

20 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

21 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

22 What else could we do with EQA data?

23 Identifying problem assays with EQA using Sigma metrics Achievable Standard: Assay Capability of 20th percentile QAP laboratory Cps<4 4<Cps<6 Cps>6 Na, K, Cl, CO 2, Ca, Ck, Tbil, Osml, hcg, drugs, CKMB, Ferr*, Fruc* Urea, Creat, Mg, PO 4, Alb, Alp, Alt, Ast, Urate, Lactate, Trig, HDL, Chollipids, Cbil-neonate* Glucose, Cbil, Prot, GGT, Amyl, Lip, LD, Chol, Fe, TIBC, Trf, Li <20% of all labs have Cps % of all labs have Cps % of all labs have Cps 4

24 Peer Group Capability 0-4 Peer Group Capability 4-6 Peer Group Capability > 6 Our Laboratory Better than peer- Better than peer- As good as peer- Capability group cell group cell group cell >6 Our Laboratory Better than peer- As good as peer- Worse than peer- Capability group cell group cell group cell 4-6 Our Laboratory As good as peer- Worse than peer- Worse than peer- Capability group cell group cell group cell 0-4

25 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved. Other Measurements we make.

26 Measurement Comparison to standard Sigma compared to Allowable Limit or Total Error What is Allowable limit with pre-analytical error? Haemolysis? ID mixup? 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

27 Measure Frequency of Error Compare frequency and compare against peers Prioritise problems and identify most significant Significant is defined as: Hard to Identify/Fix Most impact on patient outcome FMEA 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

28 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

29 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

30

31

32

33 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

34 Fig. 1. EQA/PT program B, percentage of chemistry assays expected to achieve over 5 Sigma performance, from 27 chemistry tests. Sten A. Westgard Utilizing global data to estimate analytical performance on the Sigma scale: A global comparative analysis of methods, instruments, and manufacturers through external quality assurance and proficiency testing programs Clinical Biochemistry, 2016, Available online 4 March RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

35 Metric M= f i *m i ; f i * could depend on the importance of the measurand therefore become f i *m i ; w i is the weighting given for the measurand n i. Hence M = f i *m i / n i w i. The metric could further be modified to include a cost of test, for example M = (f i *m i + g i *c i ) / n i w i, where g i is a weight per test i (which may be the same as f i ) and c i is the cost of test i.

36 Summary Measurement improves performance Need to have a comparator Six sigma assists with application of QC rules Six sigma concepts should be applied with some caution particularly in relation to ALE

37 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved. Stable versus Capable

38 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

39 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

40 Summary FMEA may be useful in monitoring and improving processes where there is no practical ALE 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

41 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved. Questions?

42 We can represent this as: Xr Xc = AG = bias + SEcont*SD *SD, where AG is analytical goal, SEcont*S represents the size of error detected by the QC algorithm, 1.65 gives a 5% chance of results falling outside the acceptable range and SD is the measured imprecision. Next we consider the critical shift a QC algorithm must detect at 90% Ped; SEcrit = [(AG bias)/imprecision] 1.65 If we express all the components in SD units then, SEcrit = Cpa 1.65; and if bias is AG/8, SEcrit = Cpa*7/ RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

43 Assay Capability, Cpa = AG/CVa Assay Capability to maintain 90% Error Detection versus SEdrift % 5% 10% 15% 20% 25% 30% 35% 40% 45% SEdrift (bias as fraction of Analytcal Goal (AG) Cpa if using MR1 Cpa if using MR RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

44 We have shown that two points of Westgard approach need to be corrected. The first is that in the presence of bias, SM CV and SM σ are not identical and we cannot use CV instead of σ. The second is that the SM value obtained from SM CV and SM σ is always lower than the real SM σ. To calculate the SM of a process, we should use the z transformation instead of SM CV and SM σ RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

45 In the N distribution, the data around l are symmetrical and the areas under the curve of both sides of l are equal (a). In the presence of a bias, the curve moves to the side of the bias, but the tolerance limits do not move. Consequently, the areas under the curve on the right and left sides around l are not equal (b). In case c, although the bias is larger than TEa, i.e., l is shifted beyond UL, the SM value of the process remains [0, since a (small) fraction of the area lies within the tolerance limits (the area between LL and UL) 2012 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

On-Site Routine/STAT Laboratory Tests. This policy provides information regarding approved procedures performed at each site

On-Site Routine/STAT Laboratory Tests. This policy provides information regarding approved procedures performed at each site Purpose: Policy: This policy provides information regarding approved procedures performed at each site This policy provides a list of laboratory tests performed on-site in each AHS Central Zone Northeast

More information

Standardized Data Percentiles, Quartiles and Box Plots Grouped Data Skewness and Kurtosis

Standardized Data Percentiles, Quartiles and Box Plots Grouped Data Skewness and Kurtosis Descriptive Statistics (Part 2) 4 Chapter Percentiles, Quartiles and Box Plots Grouped Data Skewness and Kurtosis McGraw-Hill/Irwin Copyright 2009 by The McGraw-Hill Companies, Inc. Chebyshev s Theorem

More information

ECON 214 Elements of Statistics for Economists

ECON 214 Elements of Statistics for Economists ECON 214 Elements of Statistics for Economists Session 3 Presentation of Data: Numerical Summary Measures Part 2 Lecturer: Dr. Bernardin Senadza, Dept. of Economics Contact Information: bsenadza@ug.edu.gh

More information

Measuring Measuring Errors

Measuring Measuring Errors Measuring Measuring Errors Backgound An important part of statistical analysis, perhaps the most important part, is the identification and quantification of sources of variation. For example, in a t-test

More information

ABAXIS, INC. (Exact name of registrant as specified in its charter)

ABAXIS, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended

More information

Numerical Descriptions of Data

Numerical Descriptions of Data Numerical Descriptions of Data Measures of Center Mean x = x i n Excel: = average ( ) Weighted mean x = (x i w i ) w i x = data values x i = i th data value w i = weight of the i th data value Median =

More information

Agilent Technologies. Q3'18 Results Presentation

Agilent Technologies. Q3'18 Results Presentation Agilent Technologies Q3'18 Results Presentation Safe Harbor This presentation contains forward-looking statements (including, without limitation, information and future guidance on the company s goals,

More information

My poster in 180 seconds : Evaluation of alternative robust methods for anti-drug antibodies cut-point determination

My poster in 180 seconds : Evaluation of alternative robust methods for anti-drug antibodies cut-point determination Cultura RM Exclusive/Edwin Han Jimenez/GettyImages Lans/GettyImages My poster in 180 seconds : Evaluation of alternative robust methods for anti-drug antibodies cut-point Non Clinical Statistics Conference

More information

9/17/2015. Basic Statistics for the Healthcare Professional. Relax.it won t be that bad! Purpose of Statistic. Objectives

9/17/2015. Basic Statistics for the Healthcare Professional. Relax.it won t be that bad! Purpose of Statistic. Objectives Basic Statistics for the Healthcare Professional 1 F R A N K C O H E N, M B B, M P A D I R E C T O R O F A N A L Y T I C S D O C T O R S M A N A G E M E N T, LLC Purpose of Statistic 2 Provide a numerical

More information

DATA SUMMARIZATION AND VISUALIZATION

DATA SUMMARIZATION AND VISUALIZATION APPENDIX DATA SUMMARIZATION AND VISUALIZATION PART 1 SUMMARIZATION 1: BUILDING BLOCKS OF DATA ANALYSIS 294 PART 2 PART 3 PART 4 VISUALIZATION: GRAPHS AND TABLES FOR SUMMARIZING AND ORGANIZING DATA 296

More information

CHAPTER 8 Risk and Rates of Return

CHAPTER 8 Risk and Rates of Return CHAPTER 8 Risk and Rates of Return Stand-alone risk Portfolio risk Risk & return: CAPM The basic goal of the firm is to: maximize shareholder wealth! 1 Investment returns The rate of return on an investment

More information

STAB22 section 1.3 and Chapter 1 exercises

STAB22 section 1.3 and Chapter 1 exercises STAB22 section 1.3 and Chapter 1 exercises 1.101 Go up and down two times the standard deviation from the mean. So 95% of scores will be between 572 (2)(51) = 470 and 572 + (2)(51) = 674. 1.102 Same idea

More information

Comparison of OLS and LAD regression techniques for estimating beta

Comparison of OLS and LAD regression techniques for estimating beta Comparison of OLS and LAD regression techniques for estimating beta 26 June 2013 Contents 1. Preparation of this report... 1 2. Executive summary... 2 3. Issue and evaluation approach... 4 4. Data... 6

More information

Evaluation of Proficiency Testing Results and the elimination of Statistical Outliers. Mr. Neville Tayler South African National Accreditation System

Evaluation of Proficiency Testing Results and the elimination of Statistical Outliers. Mr. Neville Tayler South African National Accreditation System Evaluation of Proficiency Testing Results and the elimination of Statistical Outliers. Mr. Neville Tayler South African National Accreditation System Introduction Various statistical tools are available

More information

value BE.104 Spring Biostatistics: Distribution and the Mean J. L. Sherley

value BE.104 Spring Biostatistics: Distribution and the Mean J. L. Sherley BE.104 Spring Biostatistics: Distribution and the Mean J. L. Sherley Outline: 1) Review of Variation & Error 2) Binomial Distributions 3) The Normal Distribution 4) Defining the Mean of a population Goals:

More information

Random variables The binomial distribution The normal distribution Other distributions. Distributions. Patrick Breheny.

Random variables The binomial distribution The normal distribution Other distributions. Distributions. Patrick Breheny. Distributions February 11 Random variables Anything that can be measured or categorized is called a variable If the value that a variable takes on is subject to variability, then it the variable is a random

More information

MEASURES OF DISPERSION, RELATIVE STANDING AND SHAPE. Dr. Bijaya Bhusan Nanda,

MEASURES OF DISPERSION, RELATIVE STANDING AND SHAPE. Dr. Bijaya Bhusan Nanda, MEASURES OF DISPERSION, RELATIVE STANDING AND SHAPE Dr. Bijaya Bhusan Nanda, CONTENTS What is measures of dispersion? Why measures of dispersion? How measures of dispersions are calculated? Range Quartile

More information

Random variables The binomial distribution The normal distribution Sampling distributions. Distributions. Patrick Breheny.

Random variables The binomial distribution The normal distribution Sampling distributions. Distributions. Patrick Breheny. Distributions September 17 Random variables Anything that can be measured or categorized is called a variable If the value that a variable takes on is subject to variability, then it the variable is a

More information

Some Characteristics of Data

Some Characteristics of Data Some Characteristics of Data Not all data is the same, and depending on some characteristics of a particular dataset, there are some limitations as to what can and cannot be done with that data. Some key

More information

Nanogen Epoch Biosciences Merger Frequently Asked Questions

Nanogen Epoch Biosciences Merger Frequently Asked Questions Filed by Nanogen, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Epoch Biosciences, Inc.

More information

Compensation Information. Contents. Introduction... 4 Salary Ranges- For Small and Medium Sized Companies... 5 Commercial Lab... 6 Sales Reps...

Compensation Information. Contents. Introduction... 4 Salary Ranges- For Small and Medium Sized Companies... 5 Commercial Lab... 6 Sales Reps... Contents Introduction... 4 Salary Ranges- For Small and Medium Sized Companies... 5 Commercial Lab... 6 Sales Reps... 6 Sales Leadership... 7 MSL Medical Science Liaisons (Ph.D s, PharmD s, Genetic Counselors)...

More information

Simple Descriptive Statistics

Simple Descriptive Statistics Simple Descriptive Statistics These are ways to summarize a data set quickly and accurately The most common way of describing a variable distribution is in terms of two of its properties: Central tendency

More information

Descriptive Statistics for Educational Data Analyst: A Conceptual Note

Descriptive Statistics for Educational Data Analyst: A Conceptual Note Recommended Citation: Behera, N.P., & Balan, R. T. (2016). Descriptive statistics for educational data analyst: a conceptual note. Pedagogy of Learning, 2 (3), 25-30. Descriptive Statistics for Educational

More information

A Proposal for Harmonising Laboratory Performance Assessment Criteria in National Asbestos Fibre Counting Schemes

A Proposal for Harmonising Laboratory Performance Assessment Criteria in National Asbestos Fibre Counting Schemes PII: S0003-4878(00)00087-9 Ann. occup. Hyg., Vol. 45, No. 6, pp. 447 455, 2001 2001 British Occupational Hygiene Society Published by Elsevier Science Ltd. All rights reserved Printed in Great Britain.

More information

3.3-Measures of Variation

3.3-Measures of Variation 3.3-Measures of Variation Variation: Variation is a measure of the spread or dispersion of a set of data from its center. Common methods of measuring variation include: 1. Range. Standard Deviation 3.

More information

ECO220Y Continuous Probability Distributions: Normal Readings: Chapter 9, section 9.10

ECO220Y Continuous Probability Distributions: Normal Readings: Chapter 9, section 9.10 ECO220Y Continuous Probability Distributions: Normal Readings: Chapter 9, section 9.10 Fall 2011 Lecture 8 Part 2 (Fall 2011) Probability Distributions Lecture 8 Part 2 1 / 23 Normal Density Function f

More information

BIOS 4120: Introduction to Biostatistics Breheny. Lab #7. I. Binomial Distribution. RCode: dbinom(x, size, prob) binom.test(x, n, p = 0.

BIOS 4120: Introduction to Biostatistics Breheny. Lab #7. I. Binomial Distribution. RCode: dbinom(x, size, prob) binom.test(x, n, p = 0. BIOS 4120: Introduction to Biostatistics Breheny Lab #7 I. Binomial Distribution P(X = k) = ( n k )pk (1 p) n k RCode: dbinom(x, size, prob) binom.test(x, n, p = 0.5) P(X < K) = P(X = 0) + P(X = 1) + +

More information

Non-Inferiority Tests for the Ratio of Two Means

Non-Inferiority Tests for the Ratio of Two Means Chapter 455 Non-Inferiority Tests for the Ratio of Two Means Introduction This procedure calculates power and sample size for non-inferiority t-tests from a parallel-groups design in which the logarithm

More information

Non-Inferiority Tests for the Ratio of Two Means in a 2x2 Cross-Over Design

Non-Inferiority Tests for the Ratio of Two Means in a 2x2 Cross-Over Design Chapter 515 Non-Inferiority Tests for the Ratio of Two Means in a x Cross-Over Design Introduction This procedure calculates power and sample size of statistical tests for non-inferiority tests from a

More information

Chapter 3. Numerical Descriptive Measures. Copyright 2016 Pearson Education, Ltd. Chapter 3, Slide 1

Chapter 3. Numerical Descriptive Measures. Copyright 2016 Pearson Education, Ltd. Chapter 3, Slide 1 Chapter 3 Numerical Descriptive Measures Copyright 2016 Pearson Education, Ltd. Chapter 3, Slide 1 Objectives In this chapter, you learn to: Describe the properties of central tendency, variation, and

More information

Where s the Beef Does the Mack Method produce an undernourished range of possible outcomes?

Where s the Beef Does the Mack Method produce an undernourished range of possible outcomes? Where s the Beef Does the Mack Method produce an undernourished range of possible outcomes? Daniel Murphy, FCAS, MAAA Trinostics LLC CLRS 2009 In the GIRO Working Party s simulation analysis, actual unpaid

More information

Measure of Variation

Measure of Variation Measure of Variation Variation is the spread of a data set. The simplest measure is the range. Range the difference between the maximum and minimum data entries in the set. To find the range, the data

More information

Chapter 5: Summarizing Data: Measures of Variation

Chapter 5: Summarizing Data: Measures of Variation Chapter 5: Introduction One aspect of most sets of data is that the values are not all alike; indeed, the extent to which they are unalike, or vary among themselves, is of basic importance in statistics.

More information

Statistics 511 Supplemental Materials

Statistics 511 Supplemental Materials Gaussian (or Normal) Random Variable In this section we introduce the Gaussian Random Variable, which is more commonly referred to as the Normal Random Variable. This is a random variable that has a bellshaped

More information

BIASES OVER BIASED INFORMATION STRUCTURES:

BIASES OVER BIASED INFORMATION STRUCTURES: BIASES OVER BIASED INFORMATION STRUCTURES: Confirmation, Contradiction and Certainty Seeking Behavior in the Laboratory Gary Charness Ryan Oprea Sevgi Yuksel UCSB - UCSB UCSB October 2017 MOTIVATION News

More information

ING Life Underwriting

ING Life Underwriting ING Life Underwriting Requirements Guide June 2010 LIFE INSURANCE For agent/registered representative use only. Not for public distribution. Your future. Made easier. ING Life Insurance Underwriting June

More information

5.1 Mean, Median, & Mode

5.1 Mean, Median, & Mode 5.1 Mean, Median, & Mode definitions Mean: Median: Mode: Example 1 The Blue Jays score these amounts of runs in their last 9 games: 4, 7, 2, 4, 10, 5, 6, 7, 7 Find the mean, median, and mode: Example 2

More information

SUMMARY STATISTICS EXAMPLES AND ACTIVITIES

SUMMARY STATISTICS EXAMPLES AND ACTIVITIES Session 6 SUMMARY STATISTICS EXAMPLES AD ACTIVITIES Example 1.1 Expand the following: 1. X 2. 2 6 5 X 3. X 2 4 3 4 4. X 4 2 Solution 1. 2 3 2 X X X... X 2. 6 4 X X X X 4 5 6 5 3. X 2 X 3 2 X 4 2 X 5 2

More information

CHAPTER 5 Sampling Distributions

CHAPTER 5 Sampling Distributions CHAPTER 5 Sampling Distributions 5.1 The possible values of p^ are 0, 1/3, 2/3, and 1. These correspond to getting 0 persons with lung cancer, 1 with lung cancer, 2 with lung cancer, and all 3 with lung

More information

Statistics and Probability

Statistics and Probability Statistics and Probability Continuous RVs (Normal); Confidence Intervals Outline Continuous random variables Normal distribution CLT Point estimation Confidence intervals http://www.isrec.isb-sib.ch/~darlene/geneve/

More information

AP STATISTICS FALL SEMESTSER FINAL EXAM STUDY GUIDE

AP STATISTICS FALL SEMESTSER FINAL EXAM STUDY GUIDE AP STATISTICS Name: FALL SEMESTSER FINAL EXAM STUDY GUIDE Period: *Go over Vocabulary Notecards! *This is not a comprehensive review you still should look over your past notes, homework/practice, Quizzes,

More information

Prior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management

Prior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management This document contains both information and form fields. To read information, use the Down Arrow from a form field. Prior Authorization, Pharmacy and Health Case Management Information The purpose of this

More information

Risk Management, Qualtity Control & Statistics, part 2. Article by Kaan Etem August 2014

Risk Management, Qualtity Control & Statistics, part 2. Article by Kaan Etem August 2014 Risk Management, Qualtity Control & Statistics, part 2 Article by Kaan Etem August 2014 Risk Management, Quality Control & Statistics, part 2 BY KAAN ETEM Kaan Etem These statistical techniques, used consistently

More information

Performance and Economic Evaluation of Fraud Detection Systems

Performance and Economic Evaluation of Fraud Detection Systems Performance and Economic Evaluation of Fraud Detection Systems GCX Advanced Analytics LLC Fraud risk managers are interested in detecting and preventing fraud, but when it comes to making a business case

More information

Tests for Two Independent Sensitivities

Tests for Two Independent Sensitivities Chapter 75 Tests for Two Independent Sensitivities Introduction This procedure gives power or required sample size for comparing two diagnostic tests when the outcome is sensitivity (or specificity). In

More information

CBC... $ Lipid panel... $ GGT... $ PTT... $ 37.00

CBC... $ Lipid panel... $ GGT... $ PTT... $ 37.00 Forms Advance Beneficiary Notice of Noncoverage (ABN) Patient's Name: Identification #: ADVANCE BENEFICIARY NOTICE OF NONCOVERAGE (ABN) Note: If Medicare doesn t pay for laboratory tests below, you may

More information

Economic decision analysis: Concepts and applications

Economic decision analysis: Concepts and applications Economic decision analysis: Concepts and applications Jeffrey M. Keisler Stockholm, 23 May 2016 My background and this work Education in DA and Economics Government and industry consulting Portfolio DA

More information

ASTM D02, Dec./ Orlando Statistics Seminar

ASTM D02, Dec./ Orlando Statistics Seminar ASTM D02, Dec./ Orlando Statistics Seminar Presented by: Alex Lau, Chairman, D02.94 This brief seminar will provide : a very simple explanation on the use of statistics to estimate population parameters

More information

MA131 Lecture 8.2. The normal distribution curve can be considered as a probability distribution curve for normally distributed variables.

MA131 Lecture 8.2. The normal distribution curve can be considered as a probability distribution curve for normally distributed variables. Normal distribution curve as probability distribution curve The normal distribution curve can be considered as a probability distribution curve for normally distributed variables. The area under the normal

More information

R & R Study. Chapter 254. Introduction. Data Structure

R & R Study. Chapter 254. Introduction. Data Structure Chapter 54 Introduction A repeatability and reproducibility (R & R) study (sometimes called a gauge study) is conducted to determine if a particular measurement procedure is adequate. If the measurement

More information

Drug Prior Authorization Form Actemra (tocilizumab)

Drug Prior Authorization Form Actemra (tocilizumab) This document contains both information and form fields. To read information, use the Down Arrow from a form field. Drug Prior Authorization Form The purpose of this form is to obtain information required

More information

IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter)

IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

Sampling & Confidence Intervals

Sampling & Confidence Intervals Sampling & Confidence Intervals Mark Lunt Arthritis Research UK Epidemiology Unit University of Manchester 24/10/2017 Principles of Sampling Often, it is not practical to measure every subject in a population.

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event

More information

IDEXX Laboratories Announces First Quarter Results

IDEXX Laboratories Announces First Quarter Results FOR IMMEDIATE RELEASE Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155 IDEXX Laboratories Announces First Quarter Results WESTBROOK, Maine, IDEXX Laboratories, Inc. (NASDAQ: IDXX), today

More information

Description of the Sample and Limitations of the Data

Description of the Sample and Limitations of the Data Section 3 Description of the Sample and Limitations of the Data T his section describes the 2008 Corporate sample design, sample selection, data capture, data cleaning, and data completion. The techniques

More information

Morningstar Style Box TM Methodology

Morningstar Style Box TM Methodology Morningstar Style Box TM Methodology Morningstar Methodology Paper 28 February 208 2008 Morningstar, Inc. All rights reserved. The information in this document is the property of Morningstar, Inc. Reproduction

More information

Active vs. Passive Money Management

Active vs. Passive Money Management Synopsis Active vs. Passive Money Management April 8, 2016 by Baird s Asset Manager Research of Robert W. Baird Proponents of active and passive investment management styles have made exhaustive and valid

More information

The Control Chart for Attributes

The Control Chart for Attributes The Control Chart for Attributes Topic The Control charts for attributes The p and np charts Variable sample size Sensitivity of the p chart 1 Types of Data Variable data Product characteristic that can

More information

Applications of Dataflow Computing to Finance. Florian Widmann

Applications of Dataflow Computing to Finance. Florian Widmann Applications of Dataflow Computing to Finance Florian Widmann Overview 1. Requirement Shifts in the Financial World 2. Case 1: Real Time Margin 3. Case 2: FX Option Monitor 4. Conclusions Market Context

More information

IDEXX Laboratories Announces Second Quarter Results

IDEXX Laboratories Announces Second Quarter Results FOR IMMEDIATE RELEASE Contact: Ed Garber, Director, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces Second Quarter Results Delivers 9% organic revenue growth and $1.10 EPS, driven by double-digit

More information

Basics of Quality Risk Management. CBE Pty Ltd

Basics of Quality Risk Management. CBE Pty Ltd Basics of Quality Risk Management CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without its express written

More information

Economics 345 Applied Econometrics

Economics 345 Applied Econometrics Economics 345 Applied Econometrics Problem Set 4--Solutions Prof: Martin Farnham Problem sets in this course are ungraded. An answer key will be posted on the course website within a few days of the release

More information

Chapter 4 Variability

Chapter 4 Variability Chapter 4 Variability PowerPoint Lecture Slides Essentials of Statistics for the Behavioral Sciences Seventh Edition by Frederick J Gravetter and Larry B. Wallnau Chapter 4 Learning Outcomes 1 2 3 4 5

More information

An investment s return is your reward for investing. An investment s risk is the uncertainty of what will happen with your investment dollar.

An investment s return is your reward for investing. An investment s risk is the uncertainty of what will happen with your investment dollar. Chapter 7 An investment s return is your reward for investing. An investment s risk is the uncertainty of what will happen with your investment dollar. The relationship between risk and return is a tradeoff.

More information

Equivalence Tests for the Ratio of Two Means in a Higher- Order Cross-Over Design

Equivalence Tests for the Ratio of Two Means in a Higher- Order Cross-Over Design Chapter 545 Equivalence Tests for the Ratio of Two Means in a Higher- Order Cross-Over Design Introduction This procedure calculates power and sample size of statistical tests of equivalence of two means

More information

Big Data Utilization

Big Data Utilization Cutting edge technologies and strategies Big data utilization Big Data Utilization for Post Marketing Drug Safety Measures in Japan Kaori Yamada Office of Medical Informatics and Epidemiology (OME) Pharmaceuticals

More information

Introduction to Meta-Analysis

Introduction to Meta-Analysis Introduction to Meta-Analysis by Michael Borenstein, Larry V. Hedges, Julian P. T Higgins, and Hannah R. Rothstein PART 2 Effect Size and Precision Summary of Chapter 3: Overview Chapter 5: Effect Sizes

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Interferon Gamma- 1b (Actimmune) Reference Number: CP.PHAR.52 Effective Date: 06.01.10 Last Review Date: 02.18 Line of Business: Commercial, Health Insurance Marketplace, Medicaid Coding

More information

CHAPTER 8. Confidence Interval Estimation Point and Interval Estimates

CHAPTER 8. Confidence Interval Estimation Point and Interval Estimates CHAPTER 8. Confidence Interval Estimation Point and Interval Estimates A point estimate is a single number, a confidence interval provides additional information about the variability of the estimate Lower

More information

Allison notes there are two conditions for using fixed effects methods.

Allison notes there are two conditions for using fixed effects methods. Panel Data 3: Conditional Logit/ Fixed Effects Logit Models Richard Williams, University of Notre Dame, http://www3.nd.edu/~rwilliam/ Last revised April 2, 2017 These notes borrow very heavily, sometimes

More information

Fundamentals of Statistics

Fundamentals of Statistics CHAPTER 4 Fundamentals of Statistics Expected Outcomes Know the difference between a variable and an attribute. Perform mathematical calculations to the correct number of significant figures. Construct

More information

A SCENARIO-BASED METHOD FOR COST RISK ANALYSIS

A SCENARIO-BASED METHOD FOR COST RISK ANALYSIS A SCENARIO-BASED METHOD FOR COST RISK ANALYSIS aul R. Garvey The MITRE Corporation ABSTRACT This article presents an approach for performing an analysis of a program s cost risk. The approach is referred

More information

Embracing the Future of Care Delivery: What have we learned?

Embracing the Future of Care Delivery: What have we learned? Embracing the Future of Care Delivery: What have we learned? Robert Nesse, M.D. Senior Advisor for Healthcare Policy and Payment Reform CEO, Mayo Clinic Health System 2010-2015 2014 MFMER slide-1 Fundamental

More information

Managing Transfusion Medicine with Predictive Analytics March 1, 2016

Managing Transfusion Medicine with Predictive Analytics March 1, 2016 Managing Transfusion Medicine with Predictive Analytics March 1, 2016 Ben Cleveland, Data Scientist, UnityPoint Health Rhiannon Harms, Executive Director, Strategic Improvement and Planning Conflict of

More information

Copyright 2011 Pearson Education, Inc. Publishing as Addison-Wesley.

Copyright 2011 Pearson Education, Inc. Publishing as Addison-Wesley. Appendix: Statistics in Action Part I Financial Time Series 1. These data show the effects of stock splits. If you investigate further, you ll find that most of these splits (such as in May 1970) are 3-for-1

More information

Basic Procedure for Histograms

Basic Procedure for Histograms Basic Procedure for Histograms 1. Compute the range of observations (min. & max. value) 2. Choose an initial # of classes (most likely based on the range of values, try and find a number of classes that

More information

Statistics 13 Elementary Statistics

Statistics 13 Elementary Statistics Statistics 13 Elementary Statistics Summer Session I 2012 Lecture Notes 5: Estimation with Confidence intervals 1 Our goal is to estimate the value of an unknown population parameter, such as a population

More information

Group & Health Specialty Model Solutions Fall 2015

Group & Health Specialty Model Solutions Fall 2015 Group & Health Specialty Model Solutions Fall 2015 1. Learning Objectives: The candidate will understand pricing, risk management, and reserving for individual long duration health contracts such as Disability

More information

PHARMCHEM, INC. RELEASES ITS ANNUAL LETTER TO STOCKHOLDERS & ANNOUNCES A 20% INCREASE IN ITS ANNUAL DIVIDEND

PHARMCHEM, INC. RELEASES ITS ANNUAL LETTER TO STOCKHOLDERS & ANNOUNCES A 20% INCREASE IN ITS ANNUAL DIVIDEND ` PHARMCHEM, INC. RELEASES ITS ANNUAL LETTER TO STOCKHOLDERS & ANNOUNCES A 20% INCREASE IN ITS ANNUAL DIVIDEND December 3, 2018, Fort Worth, TX: PharmChem (the Company ) released its results for 2017 and

More information

Milliman RBRVS for Hospitals

Milliman RBRVS for Hospitals Milliman RBRVS for Hospitals Will Fox, FSA, MAAA Ed Jhu, FSA, MAAA Charlie Mills, FSA, MAAA Kevin Frodsham, ASA, MAAA What is RBRVS for Hospitals? The Milliman RBRVS for Hospitals Fee Schedule provides

More information

DESCRIPTIVE STATISTICS II. Sorana D. Bolboacă

DESCRIPTIVE STATISTICS II. Sorana D. Bolboacă DESCRIPTIVE STATISTICS II Sorana D. Bolboacă OUTLINE Measures of centrality Measures of spread Measures of symmetry Measures of localization Mainly applied on quantitative variables 2 DESCRIPTIVE STATISTICS

More information

Lecture 12: The Bootstrap

Lecture 12: The Bootstrap Lecture 12: The Bootstrap Reading: Chapter 5 STATS 202: Data mining and analysis October 20, 2017 1 / 16 Announcements Midterm is on Monday, Oct 30 Topics: chapters 1-5 and 10 of the book everything until

More information

Hematology is in our blood

Hematology is in our blood Hematology is in our blood Boule Diagnostics AB Biosurfit partnership overview December 20, 2018 Fredrik Dalborg, CEO Christina Rubenhag, CFO 2018-12-20 BOULE DIAGNOSTICS (1) Copyright 2018, Boule Diagnostics

More information

DESCRIPTIVE STATISTICS

DESCRIPTIVE STATISTICS DESCRIPTIVE STATISTICS INTRODUCTION Numbers and quantification offer us a very special language which enables us to express ourselves in exact terms. This language is called Mathematics. We will now learn

More information

For personal use only

For personal use only Advanced Molecular Diagnostic Systems 1 Dalmore Drive, Scoresby, Victoria 3179 AUSTRALIA T: +61 (0)3 9763-1287 F: +61 (0)3 9763-2817 www.generabiosystems.com Tuesday 31 January 2017 ASX Announcement GENERA

More information

Datasets to use and avoid in quantitative portfolios

Datasets to use and avoid in quantitative portfolios Datasets to use and avoid in quantitative portfolios Ankit Awasthi Quantitative Portfolio Manager, qplum www.qplum.co/events Disclosures: qplum LLC is a registered investment adviser. Information presented

More information

Risk assessment checklist - Accounting and reporting

Risk assessment checklist - Accounting and reporting Check Yes or No or N/A (where not applicable). Where a No is indicated, some action may be required to rectify the situation. Cross-references (e.g., See FN 1.01) point to the relevant policy in the First

More information

Bond Pricing AI. Liquidity Risk Management Analytics.

Bond Pricing AI. Liquidity Risk Management Analytics. Bond Pricing AI Liquidity Risk Management Analytics www.overbond.com Fixed Income Artificial Intelligence The financial services market is embracing digital processes and artificial intelligence applications

More information

NJ SPOTLIGHT ON CITIES 2016 CONFERENCE SPECIAL:

NJ SPOTLIGHT ON CITIES 2016 CONFERENCE SPECIAL: NJ SPOTLIGHT ON CITIES 2016 CONFERENCE SPECIAL: NEW JERSEYANS HAVE MIXED VIEWS ON NJ CITIES, BELIEVE SCHOOL FUNDING LAWS HAVE HAD LITTLE IMPACT IN LOCAL OR URBAN DISTRICTS and NJ Spotlight October 2016

More information

IDEXX Laboratories Announces Second Quarter Results

IDEXX Laboratories Announces Second Quarter Results FOR IMMEDIATE RELEASE Contact: Ed Garber, Director, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces Second Quarter Results Catalyst instrument placements at all-time record level of over

More information

A Scenario Based Method for Cost Risk Analysis

A Scenario Based Method for Cost Risk Analysis A Scenario Based Method for Cost Risk Analysis Paul R. Garvey The MITRE Corporation MP 05B000003, September 005 Abstract This paper presents an approach for performing an analysis of a program s cost risk.

More information

THIRD QUARTER AND 9 MONTHS BUSINESS AND FINANCIAL UPDATE

THIRD QUARTER AND 9 MONTHS BUSINESS AND FINANCIAL UPDATE 2018 THIRD QUARTER AND 9 MONTHS BUSINESS AND FINANCIAL UPDATE Forward looking statement (disclaimer) This quarterly report does not, and is not intended to, constitute or form part of, and should not be

More information

The Medicare Cost Report: A Tool for Decision Making and Strategic Development

The Medicare Cost Report: A Tool for Decision Making and Strategic Development 2014 MEGA Conference The Medicare Cost Report: A Tool for Decision Making and Strategic Development January 30, 2014 10:30 a.m. 12:00 p.m. Date or subtitle Kathy LaBrake, CPA, Partner Holly Pokrandt, CPA,

More information

Patient: DOB: MR# Home Phone: Alternate Phone: Referring MD: Primary MD: Diagnosis Age: Gender: Weight: Height: BSA BMI

Patient: DOB: MR# Home Phone: Alternate Phone: Referring MD: Primary MD: Diagnosis Age: Gender: Weight: Height: BSA BMI Patient: DOB: MR# Date of Referral Date of Evaluation Home Phone: Alternate Phone: Referring MD: Primary MD: Diagnosis Age: Gender: Weight: Height: BSA BMI Blood Type(#1) #2 ALLERGIES: DATE: _ Transfusions:

More information

ANNUAL GENERAL MEETING

ANNUAL GENERAL MEETING Virtus Health (ASX. VRT) ANNUAL GENERAL MEETING Wednesday 22nd November 2017 2.00pm AEDT DISCLAIMER The material in this presentation has been prepared by Virtus Health Limited ABN 80 129 643 492 ( Virtus

More information

Baird 2018 Global Healthcare Conference. September 5, 2018

Baird 2018 Global Healthcare Conference. September 5, 2018 Baird 2018 Global Healthcare Conference September 5, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking statements,

More information

Sutter Medical Network

Sutter Medical Network Sutter Medical Network Sutter Care Pattern Analyzer making the case for affordability Fifth National Pay for Performance Summit March 9, 2010 Michael van Duren, M.D., CMO Sutter Physician Services Colleen

More information

Cowen and Company 38 th Annual Health Care Conference. March 13, 2018

Cowen and Company 38 th Annual Health Care Conference. March 13, 2018 Cowen and Company 38 th Annual Health Care Conference March 13, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking

More information

Hierarchical Generalized Linear Models. Measurement Incorporated Hierarchical Linear Models Workshop

Hierarchical Generalized Linear Models. Measurement Incorporated Hierarchical Linear Models Workshop Hierarchical Generalized Linear Models Measurement Incorporated Hierarchical Linear Models Workshop Hierarchical Generalized Linear Models So now we are moving on to the more advanced type topics. To begin

More information